STAT3 and breast cancer: An IL‐6‐STAT3 loop was shown to mediate resistance to PI3K inhibitors by inducing epithelial–mesenchymal transition (EMT) and cancer stem cell expansion in human breast cancer cells (Yang et al., 2014).